Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
The focus of the government seems to be about how many people can get vaccinated rather than ensuring the greatest protection against severe disease and deaths.
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and the need for booster shots.
Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer booster shot.
Documents show Pfizer reached out in June 2020 for a personal meeting with federal Health Minister Greg Hunt, but instead the contact was left to a senior health department official.
You’ll read lots of different figures on this — six months, eight months, more — and that’s because the research is ongoing. We don’t yet have a concrete answer.
Most kids will be unvaccinated if schools in the two largest states re-open in term 4. There may still be community transmission, but there are measures we can take to shield kids from the virus.
A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
Not vaccinating children means living with the knowledge we haven’t done everything possible to ensure they don’t transmit COVID to more vulnerable people.
Archa Fox, The University of Western Australia e Thomas Preiss, Australian National University
Doses of the Moderna vaccine will be available in Australia from mid-September. So if you’re in an eligible group you could be offered either Pfizer or Moderna. Here’s how they compare.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute